Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models. | Synapse
March 1, 2026
Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models.
Key Points
This study aims to evaluate the metabolic effects of retatrutide in preclinical obesity models.
Utilized diet-induced obese mouse and hamster models
Administered retatrutide to assess metabolic changes
Monitored various metabolic parameters
Retatrutide resulted in significant metabolic improvements
Demonstrated efficacy in lowering obesity-related metrics
Highlighted potential for new therapeutic approaches to obesity
Abstract
Retatrutide demonstrates multiple metabolic benefits in both mouse and hamster models. Our preclinical setting will help to assess the efficacy of novel therapies targeting obesity and MASH.